USANA Health Sciences, Inc. Aktie News

NEW YORK , Oct. 27, 2025 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P SmallCap 600: Solstice Advance Materials Inc. (NASD: SOLS) will replace CarMax Inc. (NYSE: KMX) in the S&P 500, and CarMax will replace USANA Health Sciences Inc. (NYSE: USNA) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, October 31. S&P 500 and 100 c...

USANA Health Sciences, Inc. (NYSE:USNA ) Q3 2025 Earnings Call October 23, 2025 11:00 AM EDT Company Participants Andrew Masuda - Director of Investor Relations Jim Brown - CEO & President Brent Neidig - Chief Commercial Officer G. Hekking - Chief Financial Officer Walter Noot - Chief Operating Officer Kathryn Armstrong Conference Call Participants Anthony Lebiedzinski - Sidoti & Company, LLC S...

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal third quarter ended September 27, 2025. Key Financial Results Third Quarter 2025 vs. Third Quarter 2024 Net sales of $214 million versus $200 million, representing 7% year-over-year growth. Net loss of -$6.5 million versus net earnings of $10.6 million. Diluted EPS of -$0.3...

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA) (“the Company,” “USANA”) today announced that it has updated the timing of the release of its third quarter 2025 financial results, which had previously been scheduled for Tuesday, October 21, 2025. The Company will now report third quarter 2025 financial results after the close of market on Wednesday, October 22, 2025. Sh...

SALT LAKE CITY , Oct. 16, 2025 /PRNewswire/ -- USANA (NYSE:USNA), a global leader in cellular nutrition, is bringing a little more sunshine to wellness. Its top-rated Vitamin D supplement has officially earned the prestigious ConsumerLab.com Seal of Approval—a recognition reserved for products that deliver on purity, potency, and scientific precision.

USANA Health Sciences faces short-term pain as Q3 preliminary results reveal declining profitability despite modest sales growth and ongoing business transition. USNA's new Brand Partner compensation plan and Hiya acquisition are causing temporary disruptions, but management expects double-digit Hiya growth and operational improvements by 2026. Valuation remains attractive, with USNA trading at...

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced preliminary results for the third quarter ended September 27, 2025. The Company anticipates third quarter 2025 net sales will be approximately $214 million, which compares with $200 million in the prior-year period. Earnings from operations are expected to be $1.2 million for the current-year quarter, or 0...

Dr. Kathryn Armstrong named a "Leadership Excellence Award" winner SALT LAKE CITY , Oct. 6, 2025 /PRNewswire/ -- USANA (NYSE:USNA) is proud to announce that its chief scientific officer, Dr. Kathryn Armstrong, has received the Women Tech Award from the Women Tech Council of Utah. The Women Tech Award is a distinguished recognition platform that celebrates women who are significantly contributin...